This inventor holds 1 USPTO granted patent. Top assignees: Lg Life Sciences, Limited, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Takeshi Kurama
Introduction
Takeshi Kurama is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmacology, particularly through his work on melanocortin receptor agonists. His innovative approach has led to advancements in therapeutic compositions that target specific receptors in the body.
Latest Patents
Takeshi Kurama holds 1 patent related to his invention of melanocortin receptor agonists. This patent describes a compound effective as an agonist of the melanocortin receptor, along with its pharmaceutically acceptable salts, hydrates, solvates, or isomers. The agonistic composition of the melanocortin receptor, which includes this compound as an active ingredient, showcases his commitment to developing effective medical treatments.
Career Highlights
Throughout his career, Takeshi has worked with prominent companies in the pharmaceutical industry. He has been associated with LG Life Sciences and Yamanouchi Pharmaceutical Company Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Takeshi Kurama has collaborated with esteemed colleagues, including Hyeon-Joo Yim and Ryoji Hirabayashi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takeshi Kurama's work in the field of melanocortin receptor agonists exemplifies his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile